Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NT-300
NT-300
Romark eyes FDA okay for COVID antiviral despite mixed trial results
Pharmaforum
Thu, 04/15/21 - 10:49 am
Romark
antivirals
NT-300
clinical trials
COVID-19